Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
02/23/1995 | CA2169280A1 Amidine derivatives with nitric oxide synthetase activities |
02/23/1995 | CA2169187A1 Use of phenols and phenol derivatives as pharmaceutical agents with a fibrinogen-lowering action |
02/23/1995 | CA2168211A1 Method of preventing neutrophil mediated connective tissue damage |
02/23/1995 | CA2167716A1 Treatment of adverse effects associated with administration of extracellular hemoglobin |
02/23/1995 | CA2165567A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelien antagonists |
02/22/1995 | EP0639644A1 New macrolides and their use |
02/22/1995 | EP0639580A1 Sphingoglycolipid |
02/22/1995 | EP0639575A1 Bicyclic heterocycles, medicaments comprising these compounds and processes for their production |
02/22/1995 | EP0639552A1 Napthalenederivatives, their preparation and pharmaceutical compositions containing them |
02/22/1995 | EP0639368A1 Scalp care product composition |
02/22/1995 | EP0639225A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
02/22/1995 | EP0639201A1 14,16beta-ETHANO-15beta,16' -CYCLO-14beta-ESTRA-1,3,5(10)-TRIENES |
02/22/1995 | EP0639187A1 Phenylderivate as inhibitors of atp citrate lyase |
02/22/1995 | EP0639181A1 Pyridine-substituted benzyl alcohols as leukotriene antagonists |
02/22/1995 | EP0639079A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
02/22/1995 | EP0639076A1 Use of guanylate cyclase inhibitors in the treatment of shock |
02/22/1995 | EP0526502B1 Phenolic amine depigmenting and antimelanoma agents |
02/22/1995 | CN1099040A Linear adhesion inhibitor |
02/22/1995 | CN1098909A Antioxidant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds |
02/22/1995 | CN1098908A Antioxidant neuroprotective use of, and method of treatment using hydroxycarbazole compounds |
02/22/1995 | CN1027695C Heterocyclic-NMDA antagonists |
02/21/1995 | US5391776 Steroid derivatives |
02/21/1995 | US5391758 Heterocyclic amide derivatives |
02/21/1995 | US5391754 Oximination a tetrahydropyridin-3-aldehyde, alkylation with a halides, salt formation |
02/21/1995 | US5391731 Pyrroloazepine derivatives |
02/21/1995 | US5391569 Treating osteoporosis, inflammatory disorders |
02/21/1995 | US5391556 Thrombin inhibitors |
02/21/1995 | US5391550 Compositions of matter and methods for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair |
02/21/1995 | US5391547 Method using 5,10,15,20-tetrakis(4-carboxyphenyl)porphine for treating cancers of the lung |
02/21/1995 | US5391328 Apparatus for introducing and bonding gas into water |
02/19/1995 | CA2129906A1 Naphthalene derivatives, process for their preparation and pharmaceutical compositions containing them |
02/17/1995 | CA2130044A1 Macrolides and the use thereof |
02/16/1995 | WO1995004819A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
02/16/1995 | WO1995004752A1 Therapeutic peptide derivatives |
02/16/1995 | WO1995004735A1 Matrix metalloprotease inhibitors |
02/16/1995 | WO1995004729A1 Amide derivatives as 5ht1d receptor antagonists |
02/16/1995 | WO1995004720A2 Gastrin and cck receptor ligands |
02/16/1995 | WO1995004713A1 2-aminoindans as selective dopamine d3 ligands |
02/16/1995 | WO1995004538A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
02/16/1995 | WO1995004535A1 Estrogenic compounds as anti-mitotic agents |
02/16/1995 | WO1995004530A1 Endothelin receptor antagonists |
02/16/1995 | WO1995004526A1 Lupane triterpenoid derivatives |
02/16/1995 | WO1995004520A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection |
02/16/1995 | CA2169291A1 Lupane triterpenoid derivatives |
02/16/1995 | CA2168791A1 Matrix metalloprotease inhibitors |
02/16/1995 | CA2167154A1 Gastrin and cck receptor ligands |
02/16/1995 | CA2146547A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection |
02/16/1995 | CA2142349A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
02/15/1995 | EP0638572A1 Bicyclic derivatives of imidazole, process for their preparation, intermediates; their application as medicaments and pharmaceutical compostions containing them |
02/15/1995 | EP0638548A1 Urea-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
02/15/1995 | EP0638321A1 Ipriflavone and pharmaceutical compositions and their use for bone defect substitution |
02/15/1995 | EP0638317A1 Pharmaceutical composition |
02/15/1995 | EP0638311A1 Rejection inhibitor for transplants and il-1 production inhibitor |
02/15/1995 | EP0638080A1 7-DISUBSTITUTED-METHYL-4-OXO-3H -,5H --PYRROLO 3,2-d -]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME |
02/15/1995 | EP0638075A1 Thiazole or imidazole derivatives as maillard reaction inhibitors |
02/15/1995 | EP0637933A1 Method and kit for imaging and treating organs and tissues |
02/15/1995 | EP0339046B1 Leukotriene b 4 analogs |
02/15/1995 | CN1098715A 1H-indole-3-acetamide spla2 inhibitors |
02/15/1995 | CN1098714A 1H-indole-3-acetic acid hydrazide spla2 inhibitors |
02/15/1995 | CN1027640C Process for the production of new trifluoromethyl ketone substituted peptide derivatives |
02/14/1995 | US5389684 Naphthalene carboxamides |
02/14/1995 | US5389666 Administering for treatment and prevention of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer or hypertension |
02/14/1995 | US5389660 Substituted imidazo-fused 5-membered ring heterocycles as angiotensin II antagonists |
02/14/1995 | US5389659 C-linked pyrazole derivatives |
02/14/1995 | US5389650 Antiinflammatory agents, anticoagulants, antispasmodic agents |
02/14/1995 | US5389644 For increasing sensitivity of tumor cells to antitumor agents without side effects |
02/14/1995 | US5389643 Aminobenzoic acid derivatives useful for treating gastro-intestinal conditions |
02/14/1995 | US5389642 Exhibit antagonistic properties toward angiotensin(II); useful for treatment of hypertensioni, aldosteronism, cardiac insufficiency, increased intraocular pressure and disorders of the central nervous system |
02/14/1995 | US5389614 Anticoagulants |
02/14/1995 | US5389612 Phosphonic peptide inhibitors of bacterial collagenases |
02/14/1995 | US5389369 Halo peroxidase containing compositions for killing yeast and sporular microorganisms |
02/14/1995 | CA2130020A1 Sulphonylbenzyl-substituted benzimidazoles, a process for their preparation and their use in medicaments |
02/14/1995 | CA1334390C Glycoprotein growth modulation materials |
02/09/1995 | WO1995004277A1 A method for preparing and selecting pharmaceutically useful non-peptide compounds from a structurally diverse universal library |
02/09/1995 | WO1995004135A1 Fungicidal methods and compositions for killing yeast and sporular microorganisms |
02/09/1995 | WO1995004078A1 Cell adhesion protein complexes with copper |
02/09/1995 | WO1995004055A1 Thiazole derivatives as lipoxygenase inhibitors |
02/09/1995 | WO1995004052A1 Methylguanidine derivatives, methods for preparing same and compositions containing said derivatives |
02/09/1995 | WO1995004051A1 Piperazine compounds used in therapy |
02/09/1995 | WO1995004049A1 PIPERAZINE DERIVATIVES AS α1A-ADRENERGIC RECEPTOR ANTAGONISTS |
02/09/1995 | WO1995004045A1 Compounds as pde iv and tnf inhibitors |
02/09/1995 | WO1995004042A1 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists |
02/09/1995 | WO1995004040A1 Perhydroisoindole derivatives as p substance antagonists |
02/09/1995 | WO1995004039A1 2-phenylpyrrole derivatives as dopamine d3 receptor antagonists |
02/09/1995 | WO1995004037A1 2-(2-hydroxyphenyl)-5-(n-phenylmethyl-aminomethyl)-pyrroles as antipsychotic agents |
02/09/1995 | WO1995004036A1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors |
02/09/1995 | WO1995004033A1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors |
02/09/1995 | WO1995004030A1 Therapeutic compound - fatty acid conjugates |
02/09/1995 | WO1995003821A1 Prosaposin and cytokine-derived peptides as therapeutic agents |
02/09/1995 | WO1995003804A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict |
02/09/1995 | WO1995003799A1 Use of benzydamine in the treatment of pathological conditions caused by tnf |
02/09/1995 | WO1995003794A1 3-cyano-3-(3,4-disubstituted)phenylcyclohexyl-1-carboxylates |
02/09/1995 | WO1995003780A1 Cosmetic or pharmaceutical and particularly dermatological composition containing an extract of tephrosia, particularly tephrosia purpurea |
02/09/1995 | WO1995003764A1 Skin patches and methods for providing testosterone |
02/09/1995 | WO1994022437A3 Method for treating amyloidosis |
02/09/1995 | DE4428025A1 Inhibitoren der Acyl-Enzym-A-Cholesterin-O-Acyl-Transferase mit therapeutischer Wirksamkeit, ihre Verwendung und sie enthaltende pharmazeutische Zusammensetzungen Inhibitors of acyl-enzyme A: cholesterol O-acyl transferase with therapeutic efficacy, their use and pharmaceutical compositions containing them |
02/09/1995 | DE4325900A1 Trisubstituted pyrimido[5,4-d]pyrimidines for the modulation of multi-drug resistance, medicaments containing these compounds and processes for their production |
02/09/1995 | CA2168886A1 A method for preparing and selecting pharmaceutically useful non-peptide compounds from a structurally diverse universal library |
02/09/1995 | CA2168443A1 Piperazine derivatives as .alpha.1a-adrenergic receptor antagonists |
02/09/1995 | CA2168262A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict |